ENT & Allergy Deal Activity Cools Off to Begin 2022 Look For Additional PE Investor Interest Ahead

The first quarter of 2022 delivered two reported ENT practice acquisitions, coming down from a flurry of deal activity to end last year.

DOWNLOAD TO READ MORE

Share This Story, Choose Your Platform